| è´§å· | å“牌 | 产å“å称 | è§„æ ¼ | 包装ã€å‚è€ƒä»·æ ¼ | |
| M812977 | MACKLIN | äºŒç”²èƒºå››çŽ¯ç´ ç›é…¸ç› | 98% | 43å…ƒ/250mg; 100å…ƒ/1g; 364å…ƒ/5g; 1269å…ƒ/25g; 4556å…ƒ/100g; | 咨询 |
储å˜ï¼šå®¤æ¸© 状æ€ï¼šé»„色粉末或晶体 |
| M792847 | MACKLIN | äºŒç”²èƒºå››çŽ¯ç´ ç›é…¸ç› | 2mM in Water | 185å…ƒ/1ml; | 咨询 |
|
| 585588 | J&K | Minocycline Hydrochloride | 98% | 740元/1G; 2957元/5G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C23H27N3O7·HCl | | 分åé‡ | 493.94 | | MDLç¼–ç | MFCD00083669 | | EINECS ç¼–å· | 237-099-7 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— |  | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H315
H319
H335 | | 防范说明 | P261
P305+P351+P338 | | WGK | 3 | | RTECS | QI7630500 |
|
| 968736 | J&K | Minocycline Hydrochloride | 890-950 μg/mg | 314元/250MG; 944元/1G; | 咨询 |
åŸºæœ¬ä¿¡æ¯ | 分åå¼ | C23H27N3O7·HCl | | 分åé‡ | 493.94 | | MDLç¼–ç | MFCD00083669 | | EINECS ç¼–å· | 237-099-7 | | å˜å‚¨æ¡ä»¶ | Store at 2-8℃ |
å®‰å…¨ä¿¡æ¯ | 图形或å±å®³æ ‡å¿— | | | æç¤ºè¯ | Warning | | å±é™©è¯´æ˜Ž | H315
H319
H335 | | 防范说明 | P261
P305+P351+P338 | | WGK | 3 | | RTECS | QI7630500 |
|
| M9511 | Sigma-Aldrich | Minocycline Hydrochloride | powder | 1035.44元/25 MG; 2264.41元/100 MG; 4457.16元/250 MG; 12483.1元/1 G; | 咨询 |
产å“说明 一般æè¿° 化å¦ç»“æž„ï¼šå››çŽ¯ç´ åº”ç”¨ ç›é…¸ç±³è¯ºçŽ¯ç´ 已被用于： - 制备纳米脂质体以检查其对巨噬细胞的影å“
- 抑制神ç»ç‚Žç—‡ 和神ç»æ€§ç–¼ç—›
- 治疗å°é¼ GL261胶质瘤细胞胶质瘤
包装 25 mg in glass bottle
100, 250 mg in poly bottle
1 g in poly bottle
æ— åº•çŽ»ç’ƒç“¶ã€‚å†…å«ç‰©è£…在æ’入的èžåˆé”¥å†…。 生化/生ç†ä½œç”¨ ç±³è¯ºçŽ¯ç´ æ˜¯ä¸€ç§å…·æœ‰æŠ‘èŒåŠŸèƒ½çš„å¹¿è°±æŠ—ç”Ÿç´ ã€‚ç±³è¯ºçŽ¯ç´ å…·æœ‰æŠ—ç‚Žä½œç”¨ã€‚ç±³è¯ºçŽ¯ç´ å¯æŠ‘åˆ¶è„‚å¤šç³–ä»‹å¯¼çš„å·¨å™¬ç»†èƒžç‚Žæ€§ç»†èƒžå› å肿瘤åæ»å› å(TNF-α )çš„åˆ†æ³Œã€‚ç±³è¯ºçŽ¯ç´ ä»¥å‰‚é‡ä¾èµ–性方å¼æŠ‘åˆ¶å·¨å™¬ç»†èƒžå¢žæ®–ã€‚ç±³è¯ºçŽ¯ç´ å¯é€šè¿‡æŠ‘制关键的炎症酶(如诱导型一氧化氮åˆé…¶(iNOS)ã€åŸºè´¨é‡‘属蛋白酶9(MMP-9)å’Œ5-è„‚æ°§åˆé…¶)，从而抑制阿尔茨海默症#8242;æ ·æ·€ç²‰æ ·è›‹ç™½ç—…å˜å‰æ–‘å—ä¸çš„神ç»ç‚Žç—‡ã€‚ç±³è¯ºçŽ¯ç´ å¯æŠ‘制内皮细胞增殖和血管生æˆã€‚ç±³è¯ºçŽ¯ç´ å¯é€šè¿‡æŠ‘制膜型1基质金属蛋白酶(MT1-MMP)在胶质瘤ä¸è¡¨çŽ°å‡ºæŠ—è‚¿ç˜¤æ´»æ€§ã€‚ç±³è¯ºçŽ¯ç´ å¯å¢žåŠ 认知和神ç»å…ƒåˆ†åŒ–。 ç±³è¯ºçŽ¯ç´ å¯é€šè¿‡å¢žåŠ ç—›æ•è‚½/å¤å•¡è‚½FQ的功能有效地å‡è½»ç¥žç»æ€§ç–¼ç—›ã€‚ 特点和优势 该化åˆç‰©æ˜¯ç”± Tevaå¼€å‘。æµè§ˆå…¶ä»–医è¯å¼€å‘的化åˆç‰©å’Œå·²æ‰¹å‡†çš„è¯ç‰©/候选è¯ç‰©æ¸…å•ï¼Œè¯·ç‚¹å‡»æ¤å¤„。 åŸºæœ¬ä¿¡æ¯ | ç»éªŒ(实验)分åå¼ | C23H27N3O7 · HCl | | 分åé‡ | 493.94 | | EC å· | 237-099-7 | | MDLç¼–å· | MFCD00083669 | | PubChem化å¦ç‰©è´¨ç¼–å· | 24278175 | | NACRES | NA.77 |
产å“性质 | å½¢å¼ | powder | | è´¨é‡æ°´å¹³ | 200 | | 作用机制 | protein synthesis | interferes | | æŠ—ç”Ÿç´ æŠ—èŒè°± | mycobacteria | | 创始人 | Teva | | 储å˜æ¸©åº¦ | 2-8℃ | | SMILES string | Cl.CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)N(C)C | | InChI | 1S/C23H27N3O7.ClH/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28;/h5-6,9,11,17,27,29-30,33H,7-8H2,1-4H3,(H2,24,32);1H/t9-,11-,17-,23-;/m0./s1 | | InChI key | GLMUAFMGXXHGLU-VQAITOIOSA-N |
å®‰å…¨ä¿¡æ¯ | 储å˜åˆ†ç±»ä»£ç | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
m.cnreagent.com